F-CRIN, ECRIN’s French national scientific partner, certified 4 new research and investigation networks on pathologies of national interest:

On 17 January 2022 RI-VIS held its Final Meeting. The meeting celebrated the numerous accomplishments carried out by the project over the last 3 years.

The PERMIT project aims to share its findings at every stage. A first publication has been issued from the series of scoping reviews that were performed during the first year of the project.

On 3 December 2021 EMA and ECRIN offered a joint training session to the ECRIN CTU community, Implementation of the Clinical Trial Regulation (EU) No 536/2014 for academia: Live demonstration of CTIS and Q&A session.

After its initial certification last year by the French Association for St

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization.

The EULAC PerMed December newsletter is now out. In this edition you will find information on upcoming webinars, the ERA PerMed: Joint Transnational Call 2022 on Prevention in Personalised Medicine, and the ICPerMed Best Practice in Personalised Medicine Recognition 2021.

On 26 November 2021 ECRIN hosted its first CTU Day bringing together members of its CTU community from all 12 of its national networks.

The EU-Africa PerMed project just released its first newsletter. Through this first newsletter you can learn about the project, results of the scientific and policy mapping exercise and events both past and upcoming. 

On 22 November a group of PERMIT consortium members, associated partners, members of the Ethics Advisory Board and external experts gathered to brainstorm on the ethical and data protection issues of personalised medicine research.

On October 6^th, 2021, the European Commission (EC) opened a new funding call titled “Tackling diseases (Two Stage – 2022) (HORIZON-HLTH-2022-DISEASE-06-two-stage)” in the context of the 

Within the European Vaccination Research Network VACCELERATE, a new multinational vaccine trial on the immune response to a third COVID-19 vaccination, EU-COVAT-1 AGED, is underway.

In recognition of the importance of providing accessible and understandable summaries of clinical trial results to patients and the public, Good Lay Summary Practice (GLSP) Recommendations were published,  October 4th 2021 by the EU Commission in

ECRIN contributed to a policy forum “Medical journal requirements for clinical trial data sharing: Ripe for improvement” was published 25 October 2021 in PLOS Medical.